InDevR Joins Forces With Sino Biological For Enhanced Vaccine And Therapy Testing Solutions

InDevR, Inc., a prominent provider of analytical solutions for vaccine testing, and Sino Biological, Inc., a biotechnology firm listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), have announced a new partnership. This collaboration aims to expedite the development of multiplexed assays for various applications, including vaccines, mRNA therapies, and cell and gene therapy.

Sino Biological’s extensive catalog of antibodies, antigens, and other reagents will now be available for use on InDevR’s VaxArray Platform. This platform is widely used by biopharmaceutical companies globally for its multiplex assay capabilities. It simplifies and standardizes vaccine testing, aiding in the development of new vaccines, optimization of existing formulations, and production scale-up.

The two companies aim to accelerate the creation and deployment of multiparametric analytical tools. These tools will assist researchers in advancing mRNA vaccine development and the evolving field of cell and gene therapy.

Since its inception in 2003, InDevR has focused on delivering innovative analytical tools for the vaccine industry. Dr. Kathy Rowlen, CEO of InDevR, stated that the company aims to leverage its expertise to address the urgent need for improved analytical tools for cell and gene therapies and mRNA vaccine testing.

Sino Biological specializes in recombinant protein production and antibody development. The company is enthusiastic about the collaboration with InDevR. Dr. Rob Burgess, Chief Business Officer at Sino Biological, expressed excitement about enhancing the capabilities of the VaxArray Platform with their comprehensive range of quality reagents.

Expert Opinions

Dr. Kathy Rowlen emphasized that the partnership with Sino Biological would drive new product development and empower customers to design their own multiplex assays with ease. Dr. Rob Burgess highlighted that combining Sino Biological's quality reagents with InDevR's advanced analytical technology promises superior solutions for in-process and quality control testing in the biopharmaceutical industry.

About InDevR

InDevR is known for its innovative solutions for in-process, QC, and release testing of vaccines. The company is committed to enhancing the speed and accuracy of vaccine characterization. Its products and services are trusted by leading pharmaceutical companies and research institutions worldwide.

About Sino Biological

Sino Biological is an international reagent supplier and contract research service provider specializing in recombinant protein production and antibody development. The company independently develops all its products under a stringent quality management system. Their offerings include unique bioreagents addressing areas such as cell therapy, stem cell research, and infectious disease research.

Contact Information

For media inquiries or partnership opportunities:

For more information about Sino Biological, visit their website or follow them on LinkedIn or Twitter @SinoInc.